
Dr. Amin Kherani is a Clinical Associate Professor at the University of Calgary and Past President of the Canadian Retina Society. He is an active educator and vitreoretinal surgeon who has serviced the Calgary and Southern Alberta community for nearly 25 years. He completed most of his medical education including his MD and Ophthalmology Residency at the University of Alberta. He furthered his subspecialty fellowship training in Medical and Surgical Retina at the University of Iowa. He was the inaugural ophthalmology Residency Training Director at the University of Calgary, which he served for nearly 10 years. He is also the current Retina Fellowship Program Co-director which was initiated together with Dr. Geoff Williams in Calgary about 15 years ago. They also co-founded and developed a community-based group retina practice, Calgary Retina Consultants and built the Southern Alberta Eye Center. The Department of Surgery, Calgary zone has appointed Dr. Kherani to lead the Office of Surgical Fellowship for all surgical fellows at the University of Calgary. Complimenting is professional activities, he also engages actively in clinical research and has participates in numerous industry supported randomized clinical trials. He really enjoys playing tennis and is committed to his family including his dear wife Shellina and their two children, Jayhan and Imaan.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
- Abbvie
- Alcon
- Bayer
- Bausch + Lomb
- Novartis
- Allergan
- Roche
- Appellis
- Bayer
- Novartis
- Roche/Genentech
- Allergan/AbbVie
- Chengdu Kanghong
- Biotechnology
- Ophthotech
- Regeneron
- Regenexbio
- Iveris Bio Inc
- Opthea
- Alexion
- MD Collaborate
Sessions in which Amin Kherani MD participates
Friday 1 June, 2018
LEARNING OBJECTIVES:At the end of this symposium, participants will be able to:Describe the advantages and limitations of various treatment strategies for uveitis, including local and systemic therapies, and choose the most appropriate line of therapy for different uveitis presentationsIndicate the advantages and limitations of anti-VEGF agents in treating intraocular neovascularisation or macular edema secondary to uveitis vs. other vasculopathic causes of...
Sunday 3 June, 2018
Saturday 15 June, 2019
Thursday 9 June, 2022
Friday 10 June, 2022
Authors: Tyler J. Henry Gurkaran S. Sarohia, Natalia Figueiredo, Natalie Dougherty, Matthew Tennant, Alejandra Ugarte-Torres, Hoi Tai Fung, R. Geoff Williams, Michael Fielden, Anna Ells, Patrick Mitchell, Mark Greve, Rizwan Somani, Chad Baker, Brad Hinz, Mark Seamone, David Ehmann, Amin Kherani.Author Disclosure Block: T.J. Henry:
Saturday 11 June, 2022
Authors: Rajinder S. Nirwan, Natalia Figueiredo, Julia Farah, Shellina Kherani, Sarah Ha, April Ingram, Geoff Williams, Amin Kherani. Author Disclosure Block: R.S. Nirwan: None. N. Figueiredo: None. J. Farah: None. S. Kherani: None. S. Ha: None. A. Ingram: None. G. Williams: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Roche. Funded grants or clin...
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar
Thursday 19 June, 2025
Additional authors: Vania Zarza, Faazil Kassam, Martin Hyrcza
Friday 20 June, 2025
Saturday 21 June, 2025
Join us at this Accredited Symposium co-developed with COS and Roche! Chaired by Bernard Hurley and Cynthia Qian.The retinal care symposium is also taking shape. Drawing inspiration from "Who Wants to Be a Millionaire," we are developing an engaging game-show format where specialists tackle increasingly challeng...